Inpatient and Outpatient Orderable
NASH FibroSure Plus
Synonyms
|
- LAB10822
- NASH FIBROSURE
- NASHFIBRO
- NONALCOHOLIC FATTY LIVER DISEASE
|
Cerner Name
|
NASH FibroSure Plus
|
Clinical Info
|
This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
|
Specimen Types
|
Blood
|
Container
|
Gold Top Tube
|
Collection Instructions
|
Container/Tube: Red or Gold top tube Specimen: 3.5 mL serum ( 2 mL min) Transport Temperature: Refrigerated Note: Patient should be fasting for at least eight hours Causes for Rejection Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
|
Specimen Volume
|
3.5 mL serum ( 2 mL min)
|
Transport Instructions
|
Refrigerated
|
Specimen Stability
|
3 Days Room Temperature or Refrigerated 7 Days Frozen .
|
Methodology
|
The analytes tested are performed by FibroSure-Specific methods.
|
Days Performed
|
|
Performing Laboratory
|
LabCorp
|
CPT
|
82172; 82247; 82465; 82947; 82977; 83010; 83883; 84450; 84460; 84478
|
PDM
|
1559233
|
Only Orderable at Locations:
|
Orderable Everywhere
|
Results
|
Component Name |
Base Name |
Common Name |
External Name |
FIBROSIS SCORE. |
FIBROSISSCR |
FIBROSIS SCORE |
Fibrosis Score |
FIBROSIS STAGE. |
FIBROSISSTG |
FIBROSIS STAGE |
Fibrosis Stage |
STEATOSIS SCORE |
STEATSC |
STEATOSIS SCORE |
Steatosis Score |
STEATOSIS GRADE |
STEATGR |
STEATOSIS GRADE |
Steatosis Grade |
NASH SCORE |
NASHSCORE |
NASH SCORE |
NASH Score |
NASH GRADE |
NASHGRADE |
NASH GRADE |
NASH Grade |
METHODOLOGY (LABCORP) |
METHOD |
METHODOLOGY LABCORP |
Methodology |
ALPHA 2-MACROGLOBULINS, QN |
A2MACROGLQN |
ALPHA 2 MACROGLOBULINS QN |
Alpha 2-Macroglobulins, Qn |
HAPTOGLOBIN, SERUM |
HAPTOGLOBIN |
HAPTOGLOBIN |
Haptoglobin |
APOLIPOPROTEIN A-1 |
APOA1 |
APOLIPOPROTEIN A 1 |
Apolipoprotein A-1 |
BILIRUBIN, TOTAL |
BILITOT |
BILIRUBIN TOTAL |
Bilirubin, Total |
GGT |
GGT |
GGT |
GGT |
ALT (SGPT) P5P |
ALT |
ALT SGPT P5P |
ALT (SGPT) P5P |
AST (SGOT) P5P |
AST |
AST SGOT P5P |
AST (SGOT) P5P |
CHOLESTEROL, TOTAL. |
CHOL |
CHOLESTEROL, TOTAL |
Cholesterol, Total |
GLUCOSE, SERUM |
GLU |
GLUCOSE |
Glucose |
TRIGLYCERIDES. |
TRIG |
TRIGLYCERIDES |
Triglycerides |
INTERPRETATIONS |
NASHINT |
INTERPRETATIONS |
Interpretations |
FIBROSIS SCORING: |
FIBROSISSCR |
FIBROSIS SCORING |
Fibrosis Scoring |
STEATOSIS SCORING |
STEATOSISSC |
STEATOSIS SCORING |
Steatosis Scoring |
NASH SCORING |
NASHSCORE |
NASH SCORING |
NASH Scoring |
LIMITATIONS |
LIMITA |
LIMITATIONS |
Limitations |
ADDITIONAL COMMENT:. |
COMMENT |
ADDITIONAL COMMENT |
NASH Comment |
COMMENT:. |
COMMENT |
COMMENT |
Comment |
|
Result Interpretation
|
Forms
|
|
LAB10822